Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Argyros, O"'
Autor:
Orfanou, I.-M. Argyros, O. Papapetropoulos, A. Tseleni-Balafouta, S. Vougas, K. Tamvakopoulos, C.
Breast cancer (BC) is a highly heterogeneous disease encompassing multiple subtypes with different molecular and histopathological features, disease prognosis, and therapeutic responses. Among these, the Triple Negative BC form (TNBC) is an aggressiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::a2f810597a03f5bef61fd953a848bbb5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102644
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102644
Objective: A series of novel 2,4-diaminosubstituted pyrrolo[3,2-d]pyrimidines was synthesized together with their corresponding 7-phenyl or 7-isopropyl counterparts. Results: Among the target derivatives, the 7-substituted analogues exhibited interes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::dcc04433901456368f8392e4b9e1f5e7
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3022198
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3022198
Breast cancer (BrCa) remains an unmet medical need despite the revolutionary development of antibody treatments and protein kinase inhibitors. In the current study, a series of novel substituted pyridopyrazine derivatives have been rationally designe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::a56d11d5aa36a5fa07a21f135d407d91
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3022245
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3022245
Publikováno v:
Gene Therapy. Jan2011, Vol. 18 Issue 1, p82-87. 6p.
Autor:
Argyros, O1, Wong, S P2, Niceta, M2, Waddington, S N3, Howe, S J4, Coutelle, C2, Miller, A D1,5 a.miller@imperial.ac.uk, Harbottle, R P1,2
Publikováno v:
Gene Therapy. Dec2008, Vol. 15 Issue 24, p1593-1605. 13p. 1 Color Photograph, 1 Black and White Photograph, 1 Diagram, 3 Graphs.
Autor:
NICETA, Marcello, CORSELLO, Giovanni, Wong, SP, Argyros, O, Tolmachov, O, Krampitz, S, Coutelle, C, Harbottle, RP
A barrier limiting the use of nonviral vectors for gene therapy is related to the short duration of transgene expression in vivo. Development, evaluation, and optimisation of a long term transgene expression using a non viral vector is currently the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::3639d44e54a281d9eb999eacde8ad153
http://hdl.handle.net/10447/43995
http://hdl.handle.net/10447/43995
Autor:
NICETA, Marcello, CORSELLO, Giovanni, Argyros, O, Wong, SP, Waddington, S, Howe, S, Coutelle, C, Miller, AD, Harbottle, RP
Un vettore ideale dovrebbe consentire l'espressione di un transgene senza alcuna limitazione di sicurezza e di riproducibilità. Qui riportiamo lo sviluppo di un nuovo vettore NON-virale basato su DNA episomale plasmidico (pDNA) che sembra soddisfare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::96c212bdfe260e84899b8e1fe97032a6
http://hdl.handle.net/10447/43814
http://hdl.handle.net/10447/43814
Autor:
Argyros, O, Wong, SP, Waddington, S, Coutelle, C, Miller, AD, Harbottle, R., NICETA, Marcello
An ideal gene therapy vector should enable persistent transgene expression without limitations of safety and reproducibility. Here we report the development of a non-viral episomal plasmid DNA (pDNA) vector that appears to fulfil these criteria. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::aa44d56e6eb7ee286069234786e92b1f
http://hdl.handle.net/10447/43815
http://hdl.handle.net/10447/43815
Autor:
Karampelas, T., Argyros, O., Kostomitsopoulos, N., Morgan, K., Sayyad, N., Tzakos, A. G., Fokas, D., Tamvakopoulos, C.
European Journal of Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::96af5ea43409f8bdbed71242eef9daf2
http://olympias.lib.uoi.gr/jspui/handle/123456789/13724
http://olympias.lib.uoi.gr/jspui/handle/123456789/13724
Publikováno v:
In Journal of Drug Delivery Science and Technology 2011 21(4):323-330